Latest Retinoids Stories
CRANFORD, N.J., Sept. 9 /PRNewswire/ -- Triax Pharmaceuticals, LLC announced today the approval of a new, topical retinoid with an exclusive strength of tretinoin; Tretin-X 0.0375%, for the treatment of acne vulgaris.
Findings refute earlier health warning issued by the Environmental Working Group SCHAUMBURG, Ill., Aug.
MELVILLE, N.Y., July 6 /PRNewswire/ -- E. Fougera & Co., a leading specialty pharmaceutical manufacturer, announced it has received first generic approval from the FDA for Adapalene Cream 0.1% (Rx).
A senator asked the US Food and Drug Administration on Sunday to reveal findings on a possible link between a chemical found in most sunscreens and skin cancer.
FORT WORTH, Texas, June 4 /PRNewswire/ -- With such intense competition and pressure on today's teens to get into a good college, line up a strong summer internship and land the perfect summer job, many parents feel that summer is an ideal time for their teens to get ahead.
Individuals treated for acne, psoriasis or another skin condition with vitamin A analogues (retinoids) do not appear to be at increased risk of fracture.
FORT WORTH, Texas, April 13 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the availability of a new nozzle for ClobexÂ® (clobetasol propionate 0.05%) Spray, a super-potent topical steroid indicated to treat moderate to severe plaque psoriasis in patients 18 years and older.
SCHAUMBURG, Ill., April 12 /PRNewswire-USNewswire/ -- While everyone knows that getting an adequate daily dose of vitamins and minerals is important in maintaining one's overall health, many question whether or not the vitamins touted in skin care products work in reducing the signs of sun-damaged skin.
FORT WORTH, Texas, March 22 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration (FDA) approval of DifferinÂ® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne.
ALISO VIEJO, Calif., March 1 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX), today announced that it has entered into an agreement with Spear Pharmaceuticals, Inc.
- An imitative word; an onomatopoetic word.